ASC-ST.X1

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameASC-ST.X1
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSTAT transcription factors inhibitors
TargetsSTAT transcription factors
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAndroscience Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAndroscience Corporation
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A